Hermawan, A., Putri, H., & Utomo, R. Y. (2020). Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy. DARU: Journal of Pharmaceutical Sciences, 28, 685. https://doi.org/10.1007/s40199-020-00375-4
Chicago Style (17th ed.) CitationHermawan, Adam, Herwandhani Putri, and Rohmad Yudi Utomo. "Functional Network Analysis Reveals Potential Repurposing of β-blocker Atenolol for Pancreatic Cancer Therapy." DARU: Journal of Pharmaceutical Sciences 28 (2020): 685. https://doi.org/10.1007/s40199-020-00375-4.
MLA (9th ed.) CitationHermawan, Adam, et al. "Functional Network Analysis Reveals Potential Repurposing of β-blocker Atenolol for Pancreatic Cancer Therapy." DARU: Journal of Pharmaceutical Sciences, vol. 28, 2020, p. 685, https://doi.org/10.1007/s40199-020-00375-4.